British scientists have discovered that a common drug that seems to be unrelated to sexual diseases may promise to repel super-resistant gonorrhea.
The new work of the University of Brimingham (UK), which has just been published in the prestigious medical journal The Lancet, has helped many doctors around the world breathe a sigh of relief: they have found a fairly simple method to back down. cases of drug-resistant gonorrhea.
This may be the first step to the development of a regimen to treat gonorrhea - an extremely dangerous and seemingly incurable form of gonorrhea, which appeared last year.
The first case of "super gonorrhea" was recognized by the world literature as a British man. After traveling in Southeast Asia and having sex with a local girl, he returned to England and started super gonorrhea in early 2018. World Health Organization (WHO) and agencies Health He quickly went into action, and a few months later, after trying countless regimens, he could save the patient's life. Since then, there have been several cases of super-gonorrhea recorded throughout the world, while the source of suspicion - the mysterious Southeast Asian girl - has not been determined.
This time, the scientists decided to keep only one of the two antibiotics commonly used to treat gonorrhea and instead, another antibiotic used to treat ear, eye, blood infection and inflammation. The meninges are gentamicin .
Previously, people with gonorrhea and some other sexual diseases were treated with a mixture of azithromycin and ceftriaxone . However, the number of patients resistant to azithromycin is increasing. This new study decided to use only ceftriaxone as the first alternative and replace it with gentamicin for ear and eye infections for those who could not use ceftriaxone.
Drug testing in a group of 720 patients with gonorrhea showed that taking ceftriaxone helped treat up to 98% of cases and gentamicin alone helped treat 91% of cases in just 2 weeks. Earlier, the British Public Health Agency once revealed that two female patients with super gonorrhea will also participate in the test.
Scientists from many other research units say this finding is extremely important. Using a drug available to replace the drug in question is still a top priority for scientists, because the pace of research into new antibiotics of humans has long been slower than the speed of drug resistance. very sick.
Professor Hywel Williams, a spokesman for the National Institute of Health Research (UK), expressed concern that super-drug-resistant multi-drug gonorrhea and other "milder" cases of drug-resistant gonorrhea are occurring all over. bridge. Not only sexually transmitted diseases, other diseases can appear in all areas according to the current growth of the drug- resistant "specter" , which is classified by the WHO as the top global threat for human health. Abuse of antibiotics is the biggest cause of these aggressive viruses and super viruses.